The global muscle stimulator market size was valued at USD 754.1 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 3.5% from 2023 to 2030. The growing popularity of muscle stimulators among physiotherapists, technological advancements in medical devices, and emphasis on pain management therapies in sports medicine are the key factors driving the market. Moreover, the rising prevalence of musculoskeletal disorders among citizens is expected to further drive market growth. Poor body posture, lack of fitness activities, and unhealthy diet habits are common factors causing musculoskeletal disorders. According to the data by osteopaths for industry, in 2021-22, 477,000 workers in the UK had work-related musculoskeletal disorders, whereas 7.3 million working days were lost due to work-related musculoskeletal disorders in 2021/22. The work-related musculoskeletal disorders most frequently affected the "back" area, accounting for 42% of cases.
In addition, according to the World Health Organization, approximately 1.71 billion people were suffering from musculoskeletal conditions worldwide in 2022, and it was the leading cause of disabilities worldwide, with low back pain being the leading cause of disability in 160 counties.
Furthermore, the market is anticipated to experience growth in the future due to the emergence of innovative and technologically advanced products like wearable muscle stimulator devices. For instance, Neuro20 Technologies Corp, a company focused on manufacturing wearable medical devices for the treatment of neuromuscular injuries and diseases, as well as improving human performance outcomes, announced in March 2023 that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Neuro20 PRO System. This regulatory approval comes as a 510(k) pre-market clearance. The Neuro20 PRO System is a comprehensive solution that includes a full-body electrical muscle stimulator suit, accompanying software, and an operating system. It can independently stimulate 42 different muscles, individually or in various combinations of co-contraction. The system can simultaneously treat 1 to 10 patients with specific control options for individual muscles. Also, the increasing demand for wireless and portable muscle stimulators and their compatibility with smartphones is creating growth opportunities for the market players.
Growing preference for muscle stimulators among physiotherapists is further aiding the market growth. Physiotherapists are increasingly shifting from manual techniques to muscle stimulators to treat patients in clinical and home care settings as they consume less time and are more effective. Moreover, growing cases of hip flexor strain, Anterior Cruciate Ligament (ACL) tear, and hamstring strain among sports players requiring muscle stimulation therapy are further anticipated to drive the growth.
However, muscle stimulators' high cost encourages customers to opt for cheaper alternative therapies such as yoga, acupuncture, and aromatherapy. In developing countries such as China and India, yoga and acupuncture are preferred due to the convenience and flexibility of those therapies. Also, the lack of guidelines for using muscle stimulators is contributing to the increased usage of alternative therapies. This adoption of alternative therapies among the patient population is restraining market growth.
Based on products, the Transcutaneous Electrical Nerve Stimulation (TENS) segment held the largest market share of 67.5% in 2022 and is projected to maintain its dominance over the forecast period. The growing preponderance of arthritis and increasing sports injuries are prominent factors augmenting the market growth. According to the Centers for Disease Control and Prevention (CDC), in 2021, about 1 in 4 U.S. adults, or about 58.5 million people, had been diagnosed with arthritis. Arthritis is more common in women, with a share of 23.5% compared with men's 18.1%.
On the other hand, Neuromuscular Electrical Stimulation (NMES) is the fastest-growing segment during the forecast period, with a CAGR of 4.5%. This muscle stimulator is mainly used to restore or replace motor functions in patients who suffer from upper motor neuron damage due to stroke or Spinal Cord Injury (SCI). According to facts presented by the United Spinal Association in 2022, in the U.S., around 17,700 Americans suffer from spinal cord injuries every year. Most of these injuries happen due to vehicle accidents accounting for 39.3%, followed by falls at 31.8%, and the rest due to violence, sports, and other reasons.
The market is segmented based on modality into handheld, portable, and tabletop devices. Portable devices dominated the market in 2022 with a market share of 36.0% and are estimated to witness the highest CAGR of 2.7% during the forecast period. Portable muscle stimulators are used extensively for preventing muscle atrophy, relaxation of muscle spasms, managing chronic pain due to arthritis, and increasing blood circulation. Moreover, many key players in the market are offering various innovative stimulators under this segment.
For instance, the company NeuroMetrix, Inc. offers a portable pain relief kit, which is a TENS unit that fits like a brace on patients and provides stimulation for pain relief. The company Zynex, Inc. is offering JetStream, a portable system that can be used at home for treatment. OMRON Corporation is currently providing a small-sized portable electrotherapy TENS device that can be used to provide relief from sore and aching muscles. These factors are anticipated to drive the global muscle stimulator market growth over the forecast period.
Pain management, neurological disorders, musculoskeletal disorder, and others are the key application segments of the market. The pain management application is dominating the market over the forecast period. The aging population is also a significant driver for the pain management segment. With an increasing number of older adults experiencing chronic pain, there is a growing demand for safe and efficient pain management solutions. Muscle stimulators provide a viable option for this demographic, offering targeted pain relief without the potential side effects of medication. The growing usage of muscle stimulators for managing acute and chronic pain and the growing prevalence of arthritis are anticipated to drive the segment market over the forecast period.
The pain management segment is anticipated to grow significantly due to an increasing geriatric population that suffers from muscle pain and the growing prevalence of chronic pain. For instance, according to the CDC 2021, 20.9% of adults, about 51.6 million people in the U.S., were suffering from chronic pain, and 6.9% of U.S. adults, about 17.1 million people, had high-impact chronic pain. A similar situation is prevalent in many European and Asian countries. This growing prevalence of chronic pain is anticipated to drive market growth over the forecast period.
North America dominated the market in 2022 with a market share of 42.23% and is likely to maintain its position over the forecast period. The presence of key participants, large investments by governments for innovation and development of medical devices, and the early introduction of novel muscle stimulators supplement the region's growth. Moreover, the high purchasing power of consumers and increased adoption of advanced technologies and innovative medical devices are further expected to drive growth.
In Addition, the increasing adoption of non-invasive and drug-free pain management solutions is driving the market in the North American region. Many individuals are seeking alternatives to medication or invasive procedures for pain relief. Muscle stimulators provide a non-pharmacological approach to managing pain and discomfort, making them appealing to a wide range of consumers in the region.
However, Asia Pacific is anticipated to be the fastest-growing region, with a CAGR of 4.6% over the forecast period. Growing awareness related to health and fitness, increasing adoption of pain management therapies, and rising usage of smart devices for maintaining health are the key growth stimulants of the region. Moreover, increasing sports injuries in this region are poised to stir the demand for muscle stimulators during the forecast period.
The market is highly competitive, with many manufacturers accounting for most of the market share. Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies market participants use to maintain and grow their global reach. For instance, in April 2021, Theragun Inc., a health and fitness company, acquired PowerDot Inc. in a deal worth USD 34 million. With this acquisition, the company aims to integrate PowerDot’s clinical technology complement and expand its product line, making natural, cutting-edge alternatives to traditional medicine available to everybody.
Market size value in 2023
USD 785.8 million
Revenue forecast in 2030
USD 997.3 million
CAGR of 3.5% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD million and CAGR from 2023 to 2030
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Product type, modality, application, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; Saudi Arabia; South Africa; UAE; Kuwait
Key companies profiled
NeuroMetrix, Inc.; OMRON Corporation; BioMedical Life Systems, Inc.; Zynex, Inc.; EMS Physio Ltd.; DJO Global, Inc.; Beurer GmbH.
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global muscle stimulator market based on type, material, application, end-use, and region:
Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Neuromuscular Electrical Stimulation
Functional Electrical Stimulation
Transcutaneous Electrical Nerve Stimulation
Burst Mode Alternating Current
Micro Current Electrical Neuromuscular Stimulator
Modality Outlook (Revenue, USD Million, 2018 - 2030)
Application Outlook (Revenue, USD Million, 2018 - 2030)
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million, 2018 - 2030)
Middle East and Africa
b. The global muscle stimulator market size was estimated at USD 754.1 million in 2022 and is expected to reach USD 785.8 million in 2023.
b. The global muscle stimulator market is expected to grow at a compound annual growth rate of 3.5% from 2023 to 2030 to reach USD 997.3 million by 2030.
b. Transcutaneous electrical nerve stimulation dominated the muscle stimulator market with a share of 67.3% in 2022. This is attributable to the growing prevalence of arthritis and increasing sports injuries are some of the prominent factors augmenting the market growth.
b. Some key players operating in the muscle stimulator market include NeuroMetrix, Inc.; OMRON Corporation; BioMedical Life Systems, Inc.; Zynex, Inc.; EMS Physio Ltd.; DJO Global, Inc.; and Beurer GmbH.
b. Key factors that are driving the muscle stimulator market growth include the introduction of technologically advanced products such as wearable muscle stimulator devices is projected to drive the market growth in the coming years.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."